TNF alpha in rheumatoid arthritis is best described as which type of molecule?

• A. Pro-inflammatory cytokine
• B. Anti-inflammatory cytokine
• C. Enzyme
• D. Hormone

Answer: (A)

TNF alpha drives inflammation in rheumatoid arthritis as a pro-inflammatory cytokine. It’s a signaling protein produced mainly by immune cells like macrophages and T cells in response to activation. Once released, it kick-starts the inflammatory cascade by promoting leukocyte recruitment, increasing adhesion molecules on the endothelium, and boosting other inflammatory mediators such as IL-1 and IL-6, which sustains joint inflammation and pannus formation. This inflammatory environment leads to cartilage damage and bone erosion, hallmark features of RA. Because of its central role in disease activity, therapies that block TNF alpha can reduce symptoms and slow joint damage. It’s not an anti-inflammatory mediator, nor an enzyme, and while cytokines can have systemic effects, its primary classification here is as a pro-inflammatory cytokine.